Jennifer Minai Email

VP Finance . MILLENDO THERAPEUTICS

Current Roles

Employees:
6
Revenue:
$465k
About
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing's Syndrome (CS).
MILLENDO THERAPEUTICS Address
110 Miller Avenue
Ann Arbor, MI
United States
MILLENDO THERAPEUTICS Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.